SHUKRAPHAR

New Filing detected. See link for details.

- Shukra Pharmaceuticals Limited submitted financial results for the period ended September 30, 2026. - Detailed financial metrics were not provided in the announcement.

- Shukra Pharmaceuticals Limited has submitted a Revised Chartered Accountant Certificate dated September 16, 2026, in connection with its final application for changing the company name to "Shukra Medtech Limited" and the consequent symbol change. - The revised certificate replaces the earlier certificate dated August 27, 2026, to fulfill revenue and asset criteria mandates under Regulation 45 of SEBI (LODR) Regulations, 2015. - A Corrigendum to the Postal Ballot Notice was already disseminated to shareholders on September 22, 2026.

- Submitted SDD Compliance Certificate for the quarter ended September 30, 2026 pursuant to Regulation 3(5) and 3(6) of SEBI (PIT) Regulations, 2015. - Confirmed that the company maintains a Structured Digital Database with necessary access controls, audit trails, and non-tamperability. - Reported zero non-compliances for the previous quarter.

- Shukra Pharmaceuticals Limited has changed its name to Shukra Medtech Limited. - The Ministry of Corporate Affairs approved the name change and issued a fresh Certificate of Incorporation on October 12, 2026. - The reason for the change is business restructuring and alignment with future corporate strategy and technology-led operations.